Global Public Health Partnering 2010-2017: Deal trends, players and financials

Publisher Name :
Date: 01-Apr-2017
No. of pages: 1000
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Global Public Health Partnering 2010-2017: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the public health partnering deals and agreements entered into by the worlds leading healthcare companies

Global Public Health Partnering 2010 to 2017 provides the full collection of Public Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Public Health partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Public Health partnering agreement structure

Public Health partnering contract documents

Top Public Health deals by value

Most active Public Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Public Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2010. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

Report scope

Global Public Health Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

Global Public Health Partnering 2010 to 2017 includes:

Trends in Public Health dealmaking in the biopharma industry since 2010

Analysis of Public Health deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Public Health deal contract documents

Comprehensive access to over 3500 Public Health deal records

The leading Public Health deals by value since 2010

Most active Public Health dealmakers since 2010

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

In Global Public Health Partnering 2010 to 2017, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Public Health Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 200 public health deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Public Health Partnering 2010 to 2017 provides the reader with the following key benefits:

In-depth understanding of Public Health deal trends since 2010

Access Public Health deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Public Health partner companies

Comprehensive access to over 750 links to actual Public Health deals entered into by the world's biopharma companies

Indepth review of Public Health deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Public Health opportunities

Uncover companies actively partnering Public Health opportunities

Global Public Health Partnering 2010-2017: Deal trends, players and financials

Table of Contents
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Public Health dealmaking
2.1. Introduction
2.2. Public Health partnering over the years
2.3. Public Health partnering by deal type
2.4. Public Health partnering by industry sector
2.5. Public Health partnering by stage of development
2.6. Public Health partnering by technology type
2.7. Public Health partnering by therapeutic indication

Chapter 3 -Financial deal terms for Public Health partnering
3.1. Introduction
3.2. Disclosed financials terms for Public Health partnering
3.3. Public Health partnering headline values
3.4. Public Health deal upfront payments
3.5. Public Health deal milestone payments
3.6. Public Health royalty rates

Chapter 4 - Leading Public Health deals and dealmakers
4.1. Introduction
4.2. Most active in Public Health partnering
4.3. List of most active dealmakers in Public Health
4.4. Top Public Health deals by value

Chapter 5 - Public Health contract document directory
5.1. Introduction
5.2. Public Health partnering deals where contract document available

Chapter 6 - Public Health dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Public Health therapeutic target

Appendices

Appendix 1 - Directory of Public Health deals by company A-Z 2010 to 2017
Appendix 2 - Directory of Public Health deals by deal type 2010 to 2017
Appendix 3 - Directory of Public Health deals by stage of development 2010 to 2017
Appendix 4 - Directory of Public Health deals by technology type 2010 to 2017
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Table of figures
Figure 1: Public Health partnering since 2010
Figure 2: Public Health partnering by deal type since 2010
Figure 3: Public Health partnering by industry sector since 2010
Figure 4: Public Health partnering by stage of development since 2010
Figure 5: Public Health partnering by technology type since 2010
Figure 6: Public Health partnering by indication since 2010
Figure 7: Public Health deals with a headline value
Figure 8: Public Health deals with upfront payment values
Figure 9: Public Health deals with milestone payment
Figure 10: Public Health deals with royalty rates
Figure 11: Active Public Health dealmaking activity- 2010 to 2017
Figure 12: Top Public Health deals by value since 2010
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Healthcare Providers Global Group of Eight (G8) Industry Guide 2017
    Published: 12-May-2017        Price: US 1495 Onwards        Pages: 221
    Healthcare Providers Global Group of Eight (G8) Industry Guide 2017 Summary The G8 Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-lin......
  • Healthcare Providers Global Industry Guide 2017
    Published: 12-May-2017        Price: US 1495 Onwards        Pages: 340
    Healthcare Providers Global Industry Guide 2017 Summary Global Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis ......
  • Healthcare Providers Global Industry Almanac 2017
    Published: 11-May-2017        Price: US 2995 Onwards        Pages: 602
    Healthcare Providers Global Industry Almanac 2017 Summary Global Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysi......
  • Healthcare Market Global Briefing 2017 Including: Healthcare Services (hospitals, outpatient care centers, medical and diagnostic laboratories, dental clinics, ambulatory healthcare services, veterinary services), Pharmaceutical, Medical Equipment Covering: McKesson, NHS, UnitedHealth Group, CVS Health, AmerisourceBergen, Cardinal Health, Walgreens Boots Alliance, Express Scripts Holdings, Anthem, Johnson & Johnson, Aetna
    Published: 08-May-2017        Price: US 1000 Onwards        Pages: 31
    The Americas was the largest region in the healthcare market in 2016, accounting for 48% market share. Europe was the second largest region accounting for 24% market share. Asia was the third largest region accounting for 22% market share. The Healthcare Global Market Briefing provides strategists, marketers and senior management with the critical information they need to assess the healthcare market. Reasons to Purchase Get up to date informati......
  • TrendSights Analysis: Guided Health
    Published: 21-Apr-2017        Price: US 3450 Onwards        Pages: 35
    TrendSights Analysis: Guided Health Summary Guided Health falls under the Health & Wellness mega-trend. Declining public health, as shown by growing obesity rates and related lifestyle diseases, is serving as a wake-up "call to action" for global consumers - and not just the select few immersed in, and preoccupied by, living healthy lives. With interest in pursuing healthier lifestyles and maximizing quality of life on the increase, health considerations exert growing i......
  • Global Medical Waste Management Market Research Report 2017
    Published: 03-Apr-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Medical Waste Management market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Medical Waste Management in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Surgical Waste Management Market 2017-2021
    Published: 22-Mar-2017        Price: US 3500 Onwards        Pages: 70
    Waste that is generated during surgical processes is known as surgical waste. Surgical waste is both hazardous and non-hazardous. Out of the waste generated from surgeries, 85% is non-hazardous and 15% is hazardous. Surgical waste is a huge threat to the environment. Hence, it necessitates proper disposal. Annually, around 250 million surgeries are carried out across the globe, which results in the bulk generation of surgical waste. On average, annually, more than two million tons of surgical......
  • Global Chiropractic Care Market 2017-2021
    Published: 16-Mar-2017        Price: US 3500 Onwards        Pages: 70
    Chiropractic is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. It is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. The analysts forecast global chiropractic care market......
  • Global Baby Care and Mother Care Products Market – Analysis By Product, By Region, By Country: Trends, Opportunities and Forecasts (2016-2021) By Products (Nursing Bottles and Nipples, Soothers and Teethers, Breast Pumps, Breast Pads); By Region (Americas, Europe, APAC, ROW); By Country (U.S., Canada, France, Germany, China, India)
    Published: 14-Mar-2017        Price: US 1800 Onwards        Pages: 154
    Executive Summary Rising infant population among the developing countries along with the growing focus on e-commerce has led to the growth of Baby and Mother Care market. Market for Baby and Mother Care products is growing steadily on account of the rising infant population in developing economies such as India and China. Rampant urbanization in these regions has also led to rise in the number of nuclear families with both parents in the work force. As a resul......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs